Cigarette smoking acutely decreases the serum levels of the COPD biomarker sRAGE Source: International Congress 2018 – Novel findings in biomarkers of tobacco use, exposure, hazards and genetics Year: 2018
Cigarette smoking modifies the association between IL-18 levels in induced sputum and airway heperresponsiveness in asthmatics Source: Annual Congress 2008 - Cough and airway hyperresponsiveness Year: 2008
Potential association between cigarette smoking and IL-18 levels in induced sputum of healthy and asthma smokers Source: Eur Respir J 2007; 30: Suppl. 51, 363s Year: 2007
Leptin levels in induced sputum from patients with COPD are sensitive to smoking status Source: Eur Respir J 2005; 26: Suppl. 49, 660s Year: 2005
Increased levels of osteopontin in sputum supernatant in smoking asthma Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011
Age related alterations in sputum and plasma MMP-9 and TIMP-1 levels in healthy non-smokers and smokers Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010
Low plasma CC16 levels in smokers are associated with a higher risk for chronic bronchitis Source: Eur Respir J 2015; 46: 1501-1503 Year: 2015
Elevated expression of TLR4 and HBD2 but decreased levels of IP-10 in COPD with severe exacerbation Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008
Increased serum levels of LL37, HMGB1 and S100A9 during exacerbation in COPD patients Source: Eur Respir J 2015; 45: 1482-1485 Year: 2015
The influence of the COPD exacerbation treatment on the MMP-9 concentration in serum, induced sputum and BAL Source: Eur Respir J 2005; 26: Suppl. 49, 298s Year: 2005
Elevated circulating MMP-9 is associated with increased exacerbation risk in COPD: results from SPIROMICS and COPDGene Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018
Elevated serum IL-8: a biomarker indicating exacerbation-prone COPD Source: International Congress 2017 – COPD biomarkers Year: 2017
Increased sputum concentrations of total glutathion in patients with COPD who quit smoking Source: Eur Respir J 2001; 18: Suppl. 33, 365s Year: 2001
Increased levels of hyaluronan in induced sputum from COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 436s Year: 2003
Osteopontin expression is increased in serum, BAL and bronchial tissue of asymptomatic smokers Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic Year: 2009
The influence of smoking on the level of proinflammatory cytokines in patients with COPD Source: Annual Congress 2012 - Tobacco dependence and respiratory disease Year: 2012
Late Breaking Abstract - Increased serum levels of YKL-40 in male smoking chronic obstructive pulmonary disease patients associated with altered miRNA levels in alveolar macrophages Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases Year: 2020
Induction-related changes in sputum neutrophils are associated with increased sputum levels of IL-8, but not sICAM Source: Eur Respir J 2002; 20: Suppl. 38, 189s Year: 2002
Effect of smoking cessation on sputum HNP levels in COPD patients and asymptomatic smokers Source: Annual Congress 2008 - Towards smoking cessation Year: 2008
Elevated TNF-α and interleukin-6 levels in breath condensate and serum of patients with non-CF bronchiectasis: comparison to COPD Source: Eur Respir J 2005; 26: Suppl. 49, 227s Year: 2005